Search Thermo Fisher Scientific
Ion World talk insights
Explore the future of next generation sequencing
From the discovery of disease causation and development of personalised treatment options, to solving crime and seeking justice for victims, next generation sequencing solutions are playing an increasingly vital role in our lives.
At the 6th annual Ion World event, be inspired by our speakers.
What’s in our gut affects our health
About the speaker
Dr. Hugo Roume is Research Engineer at the French National Institute for Agricultural Research (INRA) in MetaGenoPolis unit (MGP) at the Research Center of Jouy-en-Josas. The unit uses molecular biology, high-throughput sequencing for shotgun metagenomics and bioinformatics analysis to rebuild each of the 300-400 bacterial genomes present in our guts and probe the differences between diseased versus normal states.
Hugo has been investigating shotgun metagenomics analysis from various environmental ecosystems for over 7 years. His main research topics focus on modelling microbial interactions at taxonomic and functional levels to better understand the microbial community structure and function relationship for ultimately driving these systems towards improving human health.
About the talk
Revealing truth in forensics—what is the state of the art and what is possible?
About the speaker
Professor Walther Parson is Associate Professor at the Institute of Legal Medicine, Innsbruck.
He helped to set up the National DNA Database Lab, oversees research in forensic analysis and is frequently asked to handle international requests for human identification, such as the Russian Tsar family. His current research focuses on next generation sequencing techniques in human identification.
About the talk
About the technology
Can we make cancer a chronic disease?
About the speaker
Professor Orla Sheils is Director of the Trinity Translational Medicine Institute (TTMI). She uses next generation sequencing to find the molecular basis for the development of cancer in order to improve disease prevention, detection, diagnosis, and treatment. She has a particular interest in developing novel molecular diagnostics and works closely with industry bringing novel technologies and applications to the translational research setting.
About the talk
About the technology
How can we realise the potential of immuno-oncology therapies?
About the speaker
Dr Albrecht Stenzinger is the head of the IPH Center for Molecular Pathology at the Institute of Pathology, University Hospital Heidelberg, Germany. He holds an MD degree from the University of Gießen (Germany), completed his residency in pathology at the Charité University Hospital in Berlin and the University Hospital Heidelberg (Germany), and is a board certified surgical pathologist and senior attending. Albrecht received postdoctoral training at the University of Heidelberg, Germany and Massachusetts General Hospital/Harvard Medical School, USA. He has a broad expertise in molecular pathology and works in the field of translational research and genetics of solid tumours.
About the talk
About the technology
 |  |
New approaches to human genetic diseases
About the speaker
Professor Alessandra Murgia is the Director of Laboratory of Molecular Genetics and Associate Professor of Pediatrics at Department of Neurosciences and Department of Woman's and Child's Health at the University of Padova. Her work focuses on understanding neurodevelopmental disorders, intellectual disability/autism spectrum disorders, early onset epilepsy, and hereditary deafness.
About the talk
State of the art of Ion Torrent technology
About the speaker
Andy is the Vice President of Product Management and Market Development for Clinical Sequencing, responsible for the development and launch of all products related to Ion Torrent NGS systems. Andy was responsible for a number of product lines and launches including the launch of the Applied BioSystems 7300/7500 and 7500 Fast Real Time PCR Systems, the 3500 and 3500 Dx Genetic Analyzers, eventually becoming the Director of the Capillary Electrophoresis business. Andy joined Ion Torrent in June 2010 during its start-up phase and subsequent purchase by Life Technologies.
About the talk
About the technology
| |
How important is creativity in research?
About the speaker
Dr. Isaac Garcia-Murillas is Senior Scientific Officer at The Institute of Cancer Research, London. His focus is on the use of circulating tumour DNA (ctDNA), and other nucleic acids, from plasma and serum, as potential biomarkers for early cancer detection, identification of subjects at risk of relapse following chemotherapy and surgery; stratifying patients to targeted therapies and identification of resistance to therapies.
About the talk
Biological discovery isn’t a linear process. In the era of next generation sequencing and the ever-increasing choice of technology for genetic analysis, what stops us from making these discoveries faster and how can we overcome them?
About the technology
Transforming reproductive health through genetic analysis
About the speaker
Dr. Luis Alcaraz is Scientific Director and cofounder of Bioarray, Spain. He uses next generation sequencing for investigating the causes of reproductive failure with the aim of improving success rates of in vitro fertilisation (IVF).
About the talk
The promise of precision medicine
About the speaker
Dr Anagh Vora MD is Sr. Medical Director at Thermo Fisher Scientific in immuno-oncology and molecular diagnostics. He is an experienced industry physician and Board Certified Pathologist (American Board of Pathology) with 10 years global medical affairs and clinical trials expertise.
About the talk
About the technology
What’s in our gut affects our health
About the speaker
Dr. Hugo Roume is Research Engineer at the French National Institute for Agricultural Research (INRA) in MetaGenoPolis unit (MGP) at the Research Center of Jouy-en-Josas. The unit uses molecular biology, high-throughput sequencing for shotgun metagenomics and bioinformatics analysis to rebuild each of the 300-400 bacterial genomes present in our guts and probe the differences between diseased versus normal states.
Hugo has been investigating shotgun metagenomics analysis from various environmental ecosystems for over 7 years. His main research topics focus on modelling microbial interactions at taxonomic and functional levels to better understand the microbial community structure and function relationship for ultimately driving these systems towards improving human health.
About the talk
Revealing truth in forensics—what is the state of the art and what is possible?
About the speaker
Professor Walther Parson is Associate Professor at the Institute of Legal Medicine, Innsbruck.
He helped to set up the National DNA Database Lab, oversees research in forensic analysis and is frequently asked to handle international requests for human identification, such as the Russian Tsar family. His current research focuses on next generation sequencing techniques in human identification.
About the talk
About the technology
Can we make cancer a chronic disease?
About the speaker
Professor Orla Sheils is Director of the Trinity Translational Medicine Institute (TTMI). She uses next generation sequencing to find the molecular basis for the development of cancer in order to improve disease prevention, detection, diagnosis, and treatment. She has a particular interest in developing novel molecular diagnostics and works closely with industry bringing novel technologies and applications to the translational research setting.
About the talk
About the technology
How can we realise the potential of immuno-oncology therapies?
About the speaker
Dr Albrecht Stenzinger is the head of the IPH Center for Molecular Pathology at the Institute of Pathology, University Hospital Heidelberg, Germany. He holds an MD degree from the University of Gießen (Germany), completed his residency in pathology at the Charité University Hospital in Berlin and the University Hospital Heidelberg (Germany), and is a board certified surgical pathologist and senior attending. Albrecht received postdoctoral training at the University of Heidelberg, Germany and Massachusetts General Hospital/Harvard Medical School, USA. He has a broad expertise in molecular pathology and works in the field of translational research and genetics of solid tumours.
About the talk
About the technology
| |
New approaches to human genetic diseases
About the speaker
Professor Alessandra Murgia is the Director of Laboratory of Molecular Genetics and Associate Professor of Pediatrics at Department of Neurosciences and Department of Woman's and Child's Health at the University of Padova. Her work focuses on understanding neurodevelopmental disorders, intellectual disability/autism spectrum disorders, early onset epilepsy, and hereditary deafness.
About the talk
State of the art of Ion Torrent technology
About the speaker
Andy is the Vice President of Product Management and Market Development for Clinical Sequencing, responsible for the development and launch of all products related to Ion Torrent NGS systems. Andy was responsible for a number of product lines and launches including the launch of the Applied BioSystems 7300/7500 and 7500 Fast Real Time PCR Systems, the 3500 and 3500 Dx Genetic Analyzers, eventually becoming the Director of the Capillary Electrophoresis business. Andy joined Ion Torrent in June 2010 during its start-up phase and subsequent purchase by Life Technologies.
About the talk
About the technology
| |
How important is creativity in research?
About the speaker
Dr. Isaac Garcia-Murillas is Senior Scientific Officer at The Institute of Cancer Research, London. His focus is on the use of circulating tumour DNA (ctDNA), and other nucleic acids, from plasma and serum, as potential biomarkers for early cancer detection, identification of subjects at risk of relapse following chemotherapy and surgery; stratifying patients to targeted therapies and identification of resistance to therapies.
About the talk
Biological discovery isn’t a linear process. In the era of next generation sequencing and the ever-increasing choice of technology for genetic analysis, what stops us from making these discoveries faster and how can we overcome them?
About the technology
Transforming reproductive health through genetic analysis
About the speaker
Dr. Luis Alcaraz is Scientific Director and cofounder of Bioarray, Spain. He uses next generation sequencing for investigating the causes of reproductive failure with the aim of improving success rates of in vitro fertilisation (IVF).
About the talk
The promise of precision medicine
About the speaker
Dr Anagh Vora MD is Sr. Medical Director at Thermo Fisher Scientific in immuno-oncology and molecular diagnostics. He is an experienced industry physician and Board Certified Pathologist (American Board of Pathology) with 10 years global medical affairs and clinical trials expertise.
About the talk
About the technology
For Research Use Only. Not for use in diagnostic procedures.